iih and glp 1 The protective role of GLP-1 in neuro-ophthalmology Novel use of GLP-1 receptor

While lifestyle interventions are often the first choice for treating overweight or obese patients, poor efficacy and difficulty in patient adherence are common issues

Para finalizar proponen incluso un algoritmo de tratamiento ( figura 2 ) donde todo pacientes con ictus o alto riesgo cardiovascular, debera recibir ar-GLP1, recomendando incluso la suspensin de otras molculas como iDPP-IV por su nulo beneficio pronstico

PubMed: 41549912 Kreider RB, et al

Lancet 330 , 13001304 (1987)

For patients with autoimmune conditions, the microdosing GLP-1 for autoimmune conditions guide addresses this specific application

[DOI] [PubMed] [Google Scholar] 75.Tucker JD, Dhanvantari S, Brubaker PL